May 26, 2021 08:32 AM IST
Shanghvi will, however, continue to be associated with the company's board in his capacity as a non-executive director and chairman, it added.
- Apr 12, 2021 10:25 AM IST
Multi-year opportunity awaits Indian vaccine manufacturers such as DRL, Gland Pharma, Aurobindo Pharma and Cadila Pharma
- Feb 11, 2021 05:35 PM IST
The whistle-blower alleged that Sun Pharma and its subsidiary, Sun Pharmaceutical Laboratories, had diverted funds through Aditya Medisales, its sole distributor in India.
- May 08, 2019 01:26 PM IST
In 2015, Shanghvi bought 23 percent stake in Suzlon for Rs 18 billion, helping the company to return to profitability after it became India’s largest convertible-bond defaulter in 2012.
- Jan 01, 2019 01:57 PM IST
The whistleblower allegations have raised governance concerns at Sun Pharma. Investors are better placed in proactively raising their concerns with the board, to ensure that the new governance structure at Sun Pharma is robust, in their compliance and intent
- Apr 04, 2017 06:49 PM IST
The Aditya Birla Group today said it has received licence from the Reserve Bank of India to start payments bank.
- Mar 07, 2017 07:18 PM IST
India's richie rich club has shrunk by 11 people since the demonetisation last November, while Mukesh Ambani remains the richest Indian with a net worth of USD 26 billion, a study showed today.
- Feb 27, 2017 10:02 PM IST
The 2-day Indian Pharma Alliance Conference concluded on Friday and speaking at the conference, Founder and MD of Sun Pharma, Dilip Shanghvi as well as Pankaj Patel of Zydus Cadila say that efforts are underway to meet global quality standards in both products and processes.
- Feb 14, 2017 03:25 PM IST
US generics business that accounts for nearly half of Sun Pharma sales grew at a moderate pace of 4 percent USD 507 million in the third quarter.
- Jan 30, 2017 08:58 PM IST
India Post Payments Bank (IPPB) today kicked off its operations by rolling out pilot services in Raipur and Ranchi.
- Jan 28, 2017 04:04 PM IST
"India Post has received payments bank licence. The service will be launched as per schedule," a Department of Posts official said.
- Jan 16, 2017 12:08 PM IST
The study, released by rights group Oxfam ahead of the World Economic Forum (WEF) annual meeting here attended by rich and powerful from across the world, showed that just 57 billionaires in India now have same wealth (USD 216 billion) as that of the bottom 70 percent population of the country.
- Jan 07, 2017 03:40 PM IST
Till now, GIC Re was the only Indian reinsurance company. It is entitled to the right of first refusal and also has the privilege of cessions which means a portion of risk is to be mandatorily ceded to it by an insurer.
- Jan 03, 2017 08:02 PM IST
Paytm today said it has received final approval of the Reserve Bank to formally launch its payments bank and it expects to start operations next month.
- Dec 21, 2016 06:24 PM IST
For investors, the Sun Pharma stock has long stood for a focus on growth, both through organic and inorganic routes. Is this lack of focus through unrelated investments the reason for its underperformance?
- Nov 23, 2016 10:16 AM IST
India‘s top pharma and media barons are lining up to have a fill of the country‘s oil blocks. Sun Pharma founder Dilip Shanghvi and media tycoon Subash Chandra are in the fray for the government‘s oil and gas blocks auction.
- Oct 22, 2016 05:58 PM IST
Sun Pharma has significant investment plans for its facility in Madhya Pradesh, the firm's Managing Director Dilip Shanghvi said on Saturday.
- Oct 20, 2016 04:10 PM IST
Similarly, Wipro's Azim Premji, the 4th richest Indian on the Forbes list, has a networth of USD 15 billion -- more than Mozambique's GDP of USD 14.7 billion.
- Sep 22, 2016 07:51 AM IST
Forbes India has released the annual India rich list and Reliance Industries' Chairman Mukesh Ambani has topped the Forbes' '100 Richest Indians' list with a net worth of USD 22.7 billion.
- Jun 08, 2016 10:09 PM IST
Over the last year, regulatory hassles have made US market tougher to navigate for Indian companies. Sun Pharmaceutical MD Dilip Shanghvi, however, says this is the time to dig in, and do more to maintain ownership of that market.
- Jun 08, 2016 08:24 AM IST
The bipartisan support for India from Democratic and Republican Senators was fantastic, said Pepsico-India Holdings Chairman and CEO D Shivakumar, adding, America's innovativeness, start-up and R&D combined with India's entrepreneurship on both product and services has a huge potential for both the countries.
- Jun 07, 2016 02:14 PM IST
RBI Governor Raghuram Rajan said he is not "overly perturbed" by surrender of Payments Bank licences by some companies but indicated that there could be a
mechanism to ensure that entities apply for licences after due diligence as there is a cost involved in vetting them
- Jun 07, 2016 08:46 AM IST
The merger between Sun and Ranbaxy achieved closure towards the end of March 2015.
- May 31, 2016 01:25 PM IST
The company also said that the pharma major will continue to build speciality business which could impact short term profitability. It also cautioned that it could lose anywhere between 5-10 percent due to pricing pressure and peer consolidation in the US.
- May 25, 2016 02:09 PM IST
Back in August 2015, when the Reserve Bank of India handed out payments bank licences to 11 candidates, little did it know that three will be pulling out within a year. The payments bank model, which the RBI envisaged as a way to reach out to the unbanked, may be looking less profitable as a venture.